美股市場個股詳情
TRVN Trevena
- 1.750
- -0.190-9.79%
延時15分鐘行情收盤價 11/01 16:00 (美東)
149.26萬總市值-30市盈率TTM
2.050最高價1.750最低價5975股成交量2.040今開1.940昨收1.11萬成交額0.71%換手率虧損市盈率(靜)85.29萬總股本19.23352周最高-0.08市淨率147.79萬流通值1.13052周最低--股息TTM84.45萬流通股8481.250歷史最高--股息率TTM15.46%振幅1.130歷史最低1.858平均價1股每手
關於Trevena公司
Trevena Inc 是一家美國生物製藥公司，專注於爲受中樞神經系統或 CNS 疾病影響的患者開發和商業化新藥。
公司介紹
公司代碼TRVN
公司名稱Trevena
上市日期2014/01/31
發行價格7.00
成立日期2007
CEOMs. Carrie L. Bourdow
所屬市場粉單
員工數量23
年結日12-31
公司地址955 Chesterbrook Boulevard,Suite 110
城市Chesterbrook
省份賓夕法尼亞州
國家美國
郵編19087
電話1-610-354-8840
董事高管
- 姓名
- 職務
- 年薪
- Carrie L. Bourdow
- Chairman of the Board, President and Chief Executive Officer
- 166.49萬
- Patricia M. Drake
- Senior Vice President and Chief Commercial Officer
- --
- Robert T. Yoder
- Senior Vice President, Chief Business Officer and Head, Commercial Operations
- --
- Barry Shin
- Executive Vice President, Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 101.36萬
- Dr. Mark A. Demitrack, M.D.
- Senior Vice President and Chief Medical Officer
- 103.22萬
- Dr. Mark H.N. Corrigan, M.D.
- Independent Director
- 5.59萬
- Jake R. Nunn
- Independent Director
- 7.61萬
- Dr. Scott Braunstein, M.D.
- Lead Independent Director
- 7.01萬
- Dr. Anne M. Phillips, M.D.
- Independent Director
- 7.61萬
- Barbara Yanni
- Independent Director
- 7.66萬
- Marvin H. Johnson, Jr
- Independent Director
- 6.11萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據